BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 19757443)

  • 21. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
    Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
    Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
    Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
    J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing outcome of surgery for stage I rectal cancer.
    Celen O; Yildirim E; Berberoglu U
    Neoplasma; 2004; 51(6):487-90. PubMed ID: 15640960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
    Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy.
    Oñate-Ocaña LF; Montesdeoca R; López-Graniel CM; Aiello-Crocifoglio V; Mondragón-Sánchez R; Cortina-Borja M; Herrera-Goepfert R; Oros-Ovalle C; Gallardo-Rincón D
    Jpn J Clin Oncol; 2004 Jun; 34(6):323-8. PubMed ID: 15333684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer.
    Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2010 May; 53(5):779-89. PubMed ID: 20389212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological grade predicts survival time associated with recurrence after resection for colorectal cancer.
    Cho YB; Chun HK; Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2009; 56(94-95):1335-40. PubMed ID: 19950787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma.
    Mäkelä J; Kiviniemi H; Laitinen S
    Hepatogastroenterology; 2002; 49(46):971-5. PubMed ID: 12143256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
    Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
    J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.